Zobrazeno 1 - 10
of 108
pro vyhledávání: '"W. Kurt Roth"'
Publikováno v:
In Hepatology 2001 34(4) Part 2:A438-A438
Publikováno v:
In Hepatology 2001 34(4) Part 2:A558-A558
Autor:
Jan Felix Drexler, Bernd Kupfer, Nadine Petersen, Rejane Maria Tommasini Grotto, Silvia Maria Corvino Rodrigues, Klaus Grywna, Marcus Panning, Augustina Annan, Giovanni Faria Silva, Jill Douglas, Evelyn S C Koay, Heidi Smuts, Eduardo M Netto, Peter Simmonds, Maria Inês de Moura Campos Pardini, W Kurt Roth, Christian Drosten
Publikováno v:
PLoS Medicine, Vol 6, Iss 2, p e31 (2009)
BackgroundDetection and quantification of hepatitis C virus (HCV) RNA is integral to diagnostic and therapeutic regimens. All molecular assays target the viral 5'-noncoding region (5'-NCR), and all show genotype-dependent variation of sensitivities a
Externí odkaz:
https://doaj.org/article/38f6f63165004e9a85c200b78d306288
Publikováno v:
Transfusion. 53:2422-2430
Background Nucleic acid amplification techniques (NAT) in routine blood donor screening considerably reduce the diagnostic window phase period. Nevertheless, several reports of false-negative NAT results were published. Here, four cases of human immu
Autor:
Ingo Schupp, Rolf Thermann, Silke De Zolt, Patrick Unverzagt, Lutz Pichl, Thorsten Bangsow, Christine Jork, Katrin de Rue, Benjamin Müller, Marijke Weber-Schehl, W. Kurt Roth, Doris Hedges
Background: Blood product safety was significantly improved by the introduction of NAT testing in the late 1990s, resulting in a strong decrease of transfusion-transmitted infections (TTIs). Due to the occurrence of HIV-1 NAT test failures as a conse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9e56e30e5645f100f65d5949a8dd29
https://europepmc.org/articles/PMC4924456/
https://europepmc.org/articles/PMC4924456/
Autor:
W. Kurt Roth
Publikováno v:
Transfusion Medicine and Hemotherapy. 37:118-122
Upon the introduction of mandatory nucleic acid amplification technology (NAT) testing in Germany for HCV, quarantining of fresh frozen plasma (FFP) was reduced in 2002 from 6 to 4 months. In 2004 HIV-1 NAT and in 2005 anti-HBc testing were introduce
Publikováno v:
Biologicals. 37:62-70
Advances in safety of blood transfusion in clinical practice principally relate to preventing transfusion-transmitted infections (TTI). Epidemiological studies of TTI have resulted in the development, standardization, and implementation of an expandi
Autor:
W. Kurt Roth, Annette Schuller
Publikováno v:
LaboratoriumsMedizin. 32:59-69
While in large clinical laboratories the implementation of total laboratory automation is continuously proceeding, this concept is mostly not suitable for small- and middle-sized laboratories or for testing laboratories of blood donation services due
Autor:
Rolf Thermann, Philipp Bruns, Sören Müller, Björn Rotter, Susanne Raulefs, W Kurt Roth, Anna Melissa Schlitter, Carsten Jäger, Klaus Hoffmeier, Fabian J. Theis, Ina Koch, Günter Kahl, Fabian Afonso-Grunz, Bo Kong, Anne Plötner, Peter Winter, Christoph W. Michalski, Ivonne Regel, Jörg Kleeff
Publikováno v:
Mol. Cancer 14:144 (2015)
Molecular Cancer
Molecular Cancer
Previous studies identified microRNAs (miRNAs) and messenger RNAs with significantly different expression between normal pancreas and pancreatic cancer (PDAC) tissues. Due to technological limitations of microarrays and real-time PCR systems these st
Autor:
Volker Czudai, Mira Mosebach, Michael Chudy, Erhard Seifried, Heinrich Scheiblauer, Michael Schmidt, C. Micha Nübling, Sigrid Nick, W. Kurt Roth, M. K. Hourfar, Elke Grünelt
Publikováno v:
Hepatology. 44:99-107
An acute hepatitis B virus (HBV) infection was diagnosed in a regular apheresis (plasma/platelet) donor by the hepatitis B surface antigen (HBsAg) assay and minipool nucleic acid amplification technology (NAT). The acute infection was confirmed by de